Langegård, Elin
Kristensson, Felipe M.
Andersson-Assarsson, Johanna C.
Peltonen, Markku
Svensson, Per-Arne
Jacobson, Peter
Ahlin, Sofie
Sjöholm, Kajsa
Carlsson, Lena M. S.
Taube, Magdalena
Clinical trials referenced in this document:
Documents that mention this clinical trial
Effects of bariatric surgery on gout incidence in the Swedish Obese Subjects study: a non-randomised, prospective, controlled intervention trial
https://doi.org/10.1136/annrheumdis-2016-209958
Effects of Bariatric Surgery in Early- and Adult-Onset Obesity in the Prospective Controlled Swedish Obese Subjects Study (Results)
https://doi.org/10.2337/dc19-1909
Association of Bariatric Surgery With Cancer Incidence in Patients With Obesity and Diabetes: Long-term Results From the Swedish Obese Subjects Study
https://doi.org/10.2337/dc21-1335
Comparison of Preoperative Remission Scores and Diabetes Duration Alone as Predictors of Durable Type 2 Diabetes Remission and Risk of Diabetes Complications After Bariatric Surgery: A Post Hoc Analysis of Participants From the Swedish Obese Subjects Study (Results)
https://doi.org/10.2337/dc20-0157
Association between FTO rs9939609 genotype and breast cancer risk after bariatric surgery in the Swedish Obese Subjects study
https://doi.org/10.1038/s41598-026-51884-2
Funding for this research was provided by:
University of Gothenburg
Article History
Received: 18 August 2025
Accepted: 30 April 2026
First Online: 6 May 2026
Declarations
:
: The authors declare no competing interests.
: Seven regional ethics review boards (Gothenburg, Lund, Linköping, Örebro, Karolinska Institute, Uppsala, and Umeå) approved the study (reference numbers 184-90 and T508-17), and written or verbal informed consent was obtained from all participants.